First approval for Bayer's new oral, once-daily anticoagulant / Marketing to start immediately / First-in-class product to demonstrate superior efficacy to standard of care / Most studied oral, direct ...
A new oral suspension formulation of Xarelto has also been approved by the FDA. The Food and Drug Administration (FDA) has approved Xarelto ® (rivaroxaban) for 2 new pediatric indications: treatment ...
Xarelto (rivaroxaban) and Eliquis (apixaban) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat or help prevent blood clots in certain ...
Dec 21 (Reuters) - Older adults taking Bayer AG's (BAYGn.DE), opens new tab blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious ...
New questions are being raised about the clinical trial of a widely used heart drug, and critics are calling for an independent investigation, after a medical device used during the study was later ...
Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The primary per protocol analysis demonstrated that rivaroxaban (Xarelto, ...
Forbes contributors publish independent expert analyses and insights. We cover issues that affect businesses in state and federal courts Plaintiffs attorneys have not decided on an argument, but that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results